AI assistant
Sending…
Ascelia Pharma — Major Shareholding Notification 2020
Oct 19, 2020
3132_iss_2020-10-19_5b05ba72-7d52-482c-a9e6-e24313ab8144.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Ascelia Pharma AB
Holder
Handelsbanken Fonder AB
Instrument
| Instrument | Aktie SE0010573113 | |
|---|---|---|
| Before the transaction | ||
| Shares | 1,436,194 | |
| Voting rights | 1,436,194 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 16/10/2020 | |
| Limit for number of shares | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,433,149 | |
| Directly held voting rights | 1,433,149 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 4.99 % | |
| Directly held voting rights | 5.08 % | |
| Indirectly held voting rights | 0 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.08 % | 1,433,149 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 5.08 % | 1,433,149 |
| Group total holdings | ||
| Voting rights 1,433,149 Percentage of voting rights 5.08 |
||
| Published 19/10/2020 15:23 |
||
| Contact Name Johanna Lindlöf |
||
| Phone 08-7012058 |
Email [email protected] | |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Ascelia Pharma
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
AGM Information
2026
May 4
AGM Information
2026
May 4
Share Issue/Capital Change
2026
Apr 30
Share Issue/Capital Change
2026
Apr 30
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 23
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Mar 30